{"data":{"id":"us-tx/tex.-government-code-549.0205","jurisdiction":"us-tx","citation":"Tex. Government Code § 549.0205","heading":"CONSIDERATIONS FOR INCLUDING DRUG ON PREFERRED DRUG LISTS.","body":"(a) In making a decision regarding the placement of a drug on each of the preferred drug lists adopted under this subchapter, the commission shall consider:\n(1) the board's recommendations under Section 549.0309;\n(2) the drug's clinical efficacy;\n(3) the price of competing drugs after deducting any federal and state rebate amounts; and\n(4) program benefit offerings solely or in conjunction with rebates and other pricing information.\n(b) The commission shall consider including on a preferred drug list:\n(1) multiple methods of delivery within each drug class, including liquid, capsule, and tablet, including an orally disintegrating tablet; and\n(2) all strengths and dosage forms of a drug.\nAdded by Acts 2023, 88th Leg., R.S., Ch. 769 (H.B. 4611), Sec. 1.01, eff. April 1, 2025.","path":["GOVERNMENT CODE","TITLE 4. EXECUTIVE BRANCH","SUBTITLE I. HEALTH AND HUMAN SERVICES","CHAPTER 549. PROVISION OF DRUGS AND DRUG INFORMATION","SUBCHAPTER E. PREFERRED DRUG LISTS"],"source_url":"https://statutes.capitol.texas.gov/Docs/GV/htm/GV.549.htm#549.0205","current_through":"89th 2nd Called Legislative Session, 2025","vintage":"","retrieved_at":"2026-08-27T01:47:16Z","sha256":"cd70248459ab56f42b6446169bb31dc616cc0c983baaf06881c8c10cbf758b61","source_id":"us-tx","stale":false,"prev":"us-tx/tex.-government-code-549.0204","next":"us-tx/tex.-government-code-549.0206"},"notice":"GroundRules: Original legal text. Not legal advice."}